Pall Corporation (PLL),a global manufacturer of filtration,separation and purification products,recently announced its intention to open an innovative Life Sciences Centre of Excellence (:COE) in Portsmouth in the U.K. This COE will be located at Pall’s new Harbourgate site and is expected to be operational in mid 2013.
The new COE will provide a complete range of advanced facilities, including cell culture, purification, analytical solutions, protein characterization and microbiological tools. It will complement Pall’s other Life Sciences Centers in the U.S. (Westborough, MA and Menlo Park, CA) and other investments in China, Singapore, and India.
Pall’s Life Science segment is focused on developing, manufacturing and selling products to customers in the Medical and Bio Pharmaceuticals marketplaces. The new Portsmouth COE is an extension of Pall’s Life Science segment and will enable it to better serve its customers. It will have a wide scientific area to house its scientists and engineers and will provide improved customer service support with a better environment and extended facilities. The COE will develop, test and validate a wide range of Pall’s new product portfolio.
Last quarter, Pall missed the Zacks Earnings Estimates by 2.37%, while Tetra Tech Inc. (TTEK) and Haemonetics Corp. (HAE) performed better. In such a scenario, with the absence of any meaningful general business expansion, margin improvements are likely to be made by the addition of new products or processes. These in turn are likely to emerge from research laboratories. Consequently, this new COE was enthusiastically pursued by Pall.
Pall currently has a Zacks Rank # 3 (Hold), while Calgon Carbon (CCC) has a better Rank, Zacks Rank # 2.
More From Zacks.com